Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Moser

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical Sciences|January 27, 2023
N-Nitrosamines Impurities in Pharmaceuticals The Abrupt Challenges that Resulted, the Evolving Science, and the Regulatory FrameworkJustin Moser, Jörg Schlingemann, Christoph Saal
Eye (London, England)|October 6, 2023
DNA mismatch repair deficiency in conjunctival melanomaAurora Rodriguez, Justin Moser, Aparna Ramasubramanian
Journal of Pharmaceutical Sciences|July 28, 2022
N-Nitrosamines Impurities in Pharmaceuticals the Abrupt Challenges They Bring and Approaches to Tackle the RiskJustin Moser, David Keire, Jörg Schlingemann, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Neoadjuvant PD-1 Inhibitors: A Tale of Two CasesDavid Baltazar, Nathalie Zeitouni, Neel Patel, et al.
Cell|July 13, 2019
Senescence Evasion in Chemotherapy: A Sweet Spot for p21Humza M Ashraf, Justin Moser, Sabrina L Spencer
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2018
Control of the Restriction Point by Rb and p21Justin Moser, Iain Miller, Dylan Carter, et al.
Case Reports in Oncological Medicine|October 2, 2025
Vedolizumab Dose Escalation Resolves Immune Checkpoint Inhibitor-Induced Colitis in Two PatientsCong Wang, Nikhil Nayee, Jacqueline M Garrick, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 6, 2019
First-line pembrolizumab therapy in a cisplatin-ineligible patient with plasmacytoid urothelial carcinoma: A case reportLindsay Hunter, Justin Moser, Caleb Sturge, et al.
Journal of Pharmaceutical Sciences|July 21, 2023
On the Risk of Nitrosamine Contamination During Drug Product Blister PackagingJinjian Zheng, Andrew Brookes, Justin Moser, et al.
The Journal of Clinical and Aesthetic Dermatology|June 20, 2025
A Review of Neoadjuvant PD-1 Inhibitors in the Setting of Cutaneous MalignanciesAriel R Darnall, David Baltazar, Dathan Hamann, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|January 27, 2023
N-Nitrosamines Impurities in Pharmaceuticals The Abrupt Challenges that Resulted, the Evolving Science, and the Regulatory FrameworkJustin Moser, Jörg Schlingemann, Christoph Saal
Eye (London, England)|October 6, 2023
DNA mismatch repair deficiency in conjunctival melanomaAurora Rodriguez, Justin Moser, Aparna Ramasubramanian
Journal of Pharmaceutical Sciences|July 28, 2022
N-Nitrosamines Impurities in Pharmaceuticals the Abrupt Challenges They Bring and Approaches to Tackle the RiskJustin Moser, David Keire, Jörg Schlingemann, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
Neoadjuvant PD-1 Inhibitors: A Tale of Two CasesDavid Baltazar, Nathalie Zeitouni, Neel Patel, et al.
Cell|July 13, 2019
Senescence Evasion in Chemotherapy: A Sweet Spot for p21Humza M Ashraf, Justin Moser, Sabrina L Spencer
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2018
Control of the Restriction Point by Rb and p21Justin Moser, Iain Miller, Dylan Carter, et al.
Case Reports in Oncological Medicine|October 2, 2025
Vedolizumab Dose Escalation Resolves Immune Checkpoint Inhibitor-Induced Colitis in Two PatientsCong Wang, Nikhil Nayee, Jacqueline M Garrick, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 6, 2019
First-line pembrolizumab therapy in a cisplatin-ineligible patient with plasmacytoid urothelial carcinoma: A case reportLindsay Hunter, Justin Moser, Caleb Sturge, et al.
Journal of Pharmaceutical Sciences|July 21, 2023
On the Risk of Nitrosamine Contamination During Drug Product Blister PackagingJinjian Zheng, Andrew Brookes, Justin Moser, et al.
The Journal of Clinical and Aesthetic Dermatology|June 20, 2025
A Review of Neoadjuvant PD-1 Inhibitors in the Setting of Cutaneous MalignanciesAriel R Darnall, David Baltazar, Dathan Hamann, et al.
Pageof 3